OpenAI, a leading artificial intelligence research lab, has made a strategic investment in Merge Labs, a brain computer interface (BCI) startup founded by CEO Sam Altman. Merge Labs, which describes itself as a research lab focused on merging biological and artificial intelligence to enhance human abilities, recently emerged from stealth mode with a significant seed funding round. OpenAI’s investment, the largest in Merge Labs’ seed round, values the startup at $850 million.
Merge Labs aims to revolutionize the field of BCIs by developing new technologies that connect with neurons using molecules instead of traditional electrodes. By utilizing deep-reaching modalities like ultrasound, the company plans to achieve noninvasive interfaces with the brain. This approach sets Merge Labs apart from competitors like Neuralink, founded by Elon Musk, which currently requires invasive surgery for implantation of computer interface chips.
The partnership between OpenAI and Merge Labs is expected to accelerate research and development in bioengineering, neuroscience, and device engineering. By leveraging AI capabilities, Merge Labs could potentially pave the way for seamless interaction between humans and advanced AI systems. This collaboration aligns with OpenAI’s vision of creating human-centered interfaces for AI technology.
In addition to Altman, Merge Labs’ co-founders include industry experts from Tools for Humanity and Forest Neurotech, bringing a wealth of experience to the startup. The team’s diverse backgrounds and expertise will be instrumental in driving innovation in the field of BCIs. Merge Labs’ board members, including the co-founders, will play key roles in shaping the company’s future direction.
As part of the investment deal, OpenAI will collaborate with Merge Labs on scientific foundation models and frontier tools to expedite progress in the field. The integration of AI operating systems with BCIs holds promise for interpreting intent, adapting to individuals, and operating reliably in diverse environments. This synergy between AI and BCIs could potentially revolutionize the way humans interact with technology.
Altman’s long-standing interest in the concept of the “merge” – the convergence of humans and machines – underscores his commitment to exploring the potential of advanced technologies. By envisioning a future where humans and AI coexist harmoniously, Altman aims to navigate the complex landscape of AI ethics and superintelligence. The merge represents a paradigm shift in how we perceive the relationship between humans and technology.
In conclusion, the collaboration between OpenAI and Merge Labs signifies a significant step towards realizing the potential of BCIs in enhancing human capabilities. By combining expertise in AI research with innovative BCI technologies, the partnership is poised to drive groundbreaking advancements in the field. As the merge between humans and machines continues to evolve, the possibilities for transformative change are endless.
